Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 455

1.

Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK.

Hematol Oncol Stem Cell Ther. 2019 Jan 11. pii: S1658-3876(18)30122-5. doi: 10.1016/j.hemonc.2018.12.003. [Epub ahead of print] Review.

2.

The strange case of Dr. Hashmi and Mr. Hyde.

Hashmi SK.

Hematol Oncol Stem Cell Ther. 2019 Jan 9. pii: S1658-3876(18)30120-1. doi: 10.1016/j.hemonc.2018.12.001. [Epub ahead of print] No abstract available.

3.

Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review.

Lavinia B, Dario SS, Guido P, Eva G, Enrico B, Filippi AR, Massa F, Maria Grazia RR.

Hematol Oncol Stem Cell Ther. 2018 Dec 31. pii: S1658-3876(18)30121-3. doi: 10.1016/j.hemonc.2018.12.002. [Epub ahead of print]

4.

A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.

Coltoff A, Shreenivas A, Afshar S, Steinberg A.

Hematol Oncol Stem Cell Ther. 2018 Dec 27. pii: S1658-3876(18)30117-1. doi: 10.1016/j.hemonc.2018.11.003. [Epub ahead of print]

5.

Ki-67 labeling index in glioblastoma; does it really matter?

Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA.

Hematol Oncol Stem Cell Ther. 2018 Dec 8. pii: S1658-3876(18)30115-8. doi: 10.1016/j.hemonc.2018.11.001. [Epub ahead of print]

6.

Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant.

Torres ME, Hashmi SK, Stevens MA, Tan AD, Callahan V, Sloan JA, Hogan WJ, Litzow MR, Roy V, Foran JM, Colon-Otero G.

Hematol Oncol Stem Cell Ther. 2018 Dec 9. pii: S1658-3876(18)30118-3. doi: 10.1016/j.hemonc.2018.11.004. [Epub ahead of print]

7.

Epstein-Barr viremia and post-transplant lymphoproliferative disorders in patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide.

Mohyuddin GR, Roller J, Shune L, Lin T, Dias A, Ganguly S, Abhyankar S, McGuirk J, Singh A.

Hematol Oncol Stem Cell Ther. 2018 Dec 9. pii: S1658-3876(18)30116-X. doi: 10.1016/j.hemonc.2018.11.002. [Epub ahead of print] No abstract available.

8.

Haploidentical related donor allogeneic hematopoietic stem cell transplantation for patient aged older than 76 years with refractory acute myeloid leukemia.

El-Cheikh J, Salem R, Massoud R, Salem C, Ghaoui N, Kanj SS, Mahfouz R, Bazarbachi A.

Hematol Oncol Stem Cell Ther. 2018 Dec 9. pii: S1658-3876(18)30119-5. doi: 10.1016/j.hemonc.2018.11.005. [Epub ahead of print] No abstract available.

9.

Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia.

Mosaad Zaki E, Mohamed Zahran A, Abdelazeem Metwaly A, Hafez R, Hussein S, Elaiw Mohammed A.

Hematol Oncol Stem Cell Ther. 2018 Oct 11. pii: S1658-3876(18)30094-3. doi: 10.1016/j.hemonc.2018.09.002. [Epub ahead of print]

10.

Durable remission of a patient with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma.

Al Aoun SM, Iqbal S, AlHalouli TM, Zaidi SZ, Motabi IH.

Hematol Oncol Stem Cell Ther. 2018 Sep 28. pii: S1658-3876(18)30096-7. doi: 10.1016/j.hemonc.2018.09.004. [Epub ahead of print]

11.

Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome.

Albert V, Arulselvi S, Agrawal D, Pati HP, Pandey RM.

Hematol Oncol Stem Cell Ther. 2018 Sep 27. pii: S1658-3876(18)30097-9. doi: 10.1016/j.hemonc.2018.09.005. [Epub ahead of print]

12.

Cutaneous light chain amyloidosis with multiple myeloma: A concise review.

Andrei M, Wang JC.

Hematol Oncol Stem Cell Ther. 2018 Sep 21. pii: S1658-3876(18)30095-5. doi: 10.1016/j.hemonc.2018.09.003. [Epub ahead of print] Review.

13.

Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation.

Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, Hashmi SK, Bridges AG, Lehman JS, El-Azhary R.

Hematol Oncol Stem Cell Ther. 2018 Sep 20. pii: S1658-3876(18)30093-1. doi: 10.1016/j.hemonc.2018.09.001. [Epub ahead of print]

14.

Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population.

Arain A, Matthiesen C.

Hematol Oncol Stem Cell Ther. 2018 Sep 8. pii: S1658-3876(18)30091-8. doi: 10.1016/j.hemonc.2018.08.001. [Epub ahead of print] Review.

15.

Combined haploidentical and umbilical cord blood transplantation for severe aplastic anemia: Unique hematopoietic reconstitution.

Vatsayan A, Hashem H, Nagle K, Cabral L, Lazarus H, Dalal J.

Hematol Oncol Stem Cell Ther. 2018 Aug 29. pii: S1658-3876(18)30092-X. doi: 10.1016/j.hemonc.2018.08.002. [Epub ahead of print] No abstract available.

16.

Kidney dysfunction after hematopoietic cell transplantation-Etiology, management, and perspectives.

JaguĊ› D, Lis K, Niemczyk L, Basak GW.

Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):195-205. doi: 10.1016/j.hemonc.2018.07.004. Epub 2018 Jul 29. Review.

17.

Autologous hematopoietic stem cell transplant is safe for elderly lymphoma patients.

Mohyuddin GR, Romanelli N, Shune L, Abhyankar S, Ganguly S, McGuirk J, Singh A.

Hematol Oncol Stem Cell Ther. 2018 Jul 29. pii: S1658-3876(18)30066-9. doi: 10.1016/j.hemonc.2018.07.003. [Epub ahead of print] No abstract available.

18.

BCL-2 overexpression overcomes cell of origin stratification in diffuse large B-cell lymphoma.

Damlaj M, Yassin R, Al-Shieban S, Pasha T, Alzahrani M, Alhejazi A, Alaskar A.

Hematol Oncol Stem Cell Ther. 2018 Jul 29. pii: S1658-3876(18)30068-2. doi: 10.1016/j.hemonc.2018.07.005. [Epub ahead of print] No abstract available.

19.

Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case series.

Lancman G, Coltoff A, Steinberg A.

Hematol Oncol Stem Cell Ther. 2018 Jul 17. pii: S1658-3876(18)30065-7. doi: 10.1016/j.hemonc.2018.07.002. [Epub ahead of print]

20.

Role of red blood cells "annexin V" and platelets "P-selectin" in patients with thalassemia.

Mahdi ZN, Al-Mudallal SS, Hameed BM.

Hematol Oncol Stem Cell Ther. 2018 Jul 17. pii: S1658-3876(18)30064-5. doi: 10.1016/j.hemonc.2018.07.001. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center